The soluble ectodomain of AXL is derived from proteolytic cleavage, and CSF levels of sAXL have been reported as biomarkers of AD, relating to markers of amyloid and neurodegeneration but also larger structure and, to some extent, improved cognition [7, 9, 66]. This evidence concerns the gene AXL and Alzheimer disease.